214 related articles for article (PubMed ID: 6318382)
41. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
42. Morphologic features of hepatitis B virus production in vitro.
Thung SN; Gerber MA
Prog Liver Dis; 1990; 9():391-404. PubMed ID: 2156305
[No Abstract] [Full Text] [Related]
43. Elevated serum testosterone levels and risk of hepatocellular carcinoma.
Yu MW; Chen CJ
Cancer Res; 1993 Feb; 53(4):790-4. PubMed ID: 8381328
[TBL] [Abstract][Full Text] [Related]
44. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma].
Jiang MD
Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):131-4, 189. PubMed ID: 7686810
[TBL] [Abstract][Full Text] [Related]
45. [Chronic hepatitis B].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
[No Abstract] [Full Text] [Related]
46. Enhanced tumorigenicity and hepatitis B virus genes in a human hepatoma cell line injected into immunosuppressed nude mice.
Shouval D; Ross R; Reid LM; Shafritz DA
Trans Assoc Am Physicians; 1981; 94():154-64. PubMed ID: 6283704
[No Abstract] [Full Text] [Related]
47. Oncogenic potential of the hepatitis B virus.
Trop Gastroenterol; 1983; 4(1):1-2. PubMed ID: 6306882
[No Abstract] [Full Text] [Related]
48. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
[TBL] [Abstract][Full Text] [Related]
49. [Hepatitis B virus and hepatoma: evidence for a cytoplasmic tumor antigen in transformed hepatocytes].
Romet-Lemonne JL; Barin F; Goudeau A; Maupas P
C R Seances Acad Sci III; 1982 Jan; 294(1):9-14. PubMed ID: 6280812
[TBL] [Abstract][Full Text] [Related]
50. [What is new in the field of viruses in hepatology?].
Buffet C
Rev Prat; 1981 Dec; 31(59):4251-4. PubMed ID: 6275485
[No Abstract] [Full Text] [Related]
51. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
[TBL] [Abstract][Full Text] [Related]
52. Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease in Nepal.
Shrestha SM; Tsuda F; Okamoto H; Tokita H; Horikita M; Tanaka T; Miyakawa Y; Mayumi M
Hepatology; 1994 Apr; 19(4):805-9. PubMed ID: 8138250
[TBL] [Abstract][Full Text] [Related]
53. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
54. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
[TBL] [Abstract][Full Text] [Related]
55. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
Yu ZY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
[TBL] [Abstract][Full Text] [Related]
56. [Primary cancer of the liver associated with Australian antigen].
Velasco M; Soerensen R; Daiber A; Carmona A; Katz R
Rev Med Chil; 1971 Sep; 99(9):831-3. PubMed ID: 4333561
[No Abstract] [Full Text] [Related]
57. Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
Bréchot C; Minami M; De Mitri S; Paterlini P
Princess Takamatsu Symp; 1995; 25():199-209. PubMed ID: 8875625
[TBL] [Abstract][Full Text] [Related]
58. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S
Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904
[TBL] [Abstract][Full Text] [Related]
59. Viral pathogenesis of hepatocellular carcinoma in the United States.
Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER
Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
[TBL] [Abstract][Full Text] [Related]
60. [Hepatitis B virus infection and hepatocellular cancer].
Baumgarten R
Z Arztl Fortbild (Jena); 1987; 81(2):63-4. PubMed ID: 3035809
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
